Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.

[1]  A. Fishman,et al.  Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance. , 1981, American heart journal.

[2]  J S Janicki,et al.  Contractile mechanics and interaction of the right and left ventricles. , 1981, The American journal of cardiology.

[3]  B. Massie,et al.  Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.

[4]  T. Levine,et al.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.

[5]  J. Cohn,et al.  Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. , 1980, The American journal of medicine.

[6]  N. Reichek,et al.  Long-term vasodilator therapy with trimazosin in chronic cardiac failure. , 1980, The New England journal of medicine.

[7]  R. Gorlin,et al.  Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.

[8]  B. Brundage,et al.  Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. , 1980, Annals of internal medicine.

[9]  R. Gorlin,et al.  Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.

[10]  R. Gorlin,et al.  Hemodynamic evaluation of hydralazine dosage in refractory heart failure , 1980, Clinical pharmacology and therapeutics.

[11]  J. Cohn,et al.  Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. , 1980, The American journal of cardiology.

[12]  W. Parmley,et al.  Metabolic Assessment of Exercise in Chronic Heart Failure Patients: Treated with Short–term Vasodilators , 1980, Circulation.

[13]  E. Braunwald,et al.  Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.

[14]  R. Peter,et al.  Oral hydralazine therapy for primary pulmonary hypertension. , 1980, The New England journal of medicine.

[15]  J. P. Gilmore,et al.  Changes in the sensitivity of left atrial receptors following reversal of heart failure. , 1979, The American journal of physiology.

[16]  B. Brundage,et al.  Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. , 1979, The American journal of cardiology.

[17]  M. Wilén,et al.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. , 1979, The American journal of medicine.

[18]  D. Fitchett,et al.  Hydralazine in the management of left ventricular failure. , 1979, The American journal of cardiology.

[19]  P. Rocha,et al.  Regional Left Ventricular Function Assessed by Contrast Angiography in Acute Myocardial Infarction , 1979, Circulation.

[20]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[21]  J. Cohn,et al.  Contrasting acute and chronic effects of nitrates on exercise capacity in heart failure , 1979 .

[22]  J. Cohn,et al.  Nitrate Therapy for Congestive Heart Failure , 1978 .

[23]  W. Aronow,et al.  Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. , 1977, The American journal of cardiology.

[24]  J. Cohn,et al.  Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.

[25]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[26]  J. Cohn,et al.  Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.

[27]  R A Bruce,et al.  Methods of exercise testing. Step test, bicycle, treadmill, isometrics. , 1974, The American journal of cardiology.

[28]  J. Forrester,et al.  Pulmonary vascular congestion in acute myocardial infarction: hemodynamic and radiologic correlations. , 1972, Annals of internal medicine.

[29]  H. Spotnitz,et al.  Effects of Chronic Right Ventricular Volume and Pressure Loading on Left Ventricular Performance , 1971, Circulation.

[30]  T. W. Moir,et al.  Effect of Left Ventricular Hypertension, Ischemia and Vasoactive Drugs on the Myocardial Distribution of Coronary Flow , 1967, Circulation research.

[31]  J. Ross,et al.  Left Ventricular Performance During Muscular Exercise in Patients with and without Cardiac Dysfunction , 1966, Circulation.

[32]  D. Moore-Jones,et al.  Radioautographic Localization of Hydralazine-1-C14 in Arterial Walls.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.